| Unique ID issued by UMIN | UMIN000063707 |
|---|---|
| Receipt number | R000072902 |
| Scientific Title | Effects of bedtime intake of taxifolin-containing tablets on oral microbiota |
| Date of disclosure of the study information | 2026/11/20 |
| Last modified on | 2026/11/20 14:47:04 |
Effects of bedtime intake of taxifolin-containing tablets on oral microbiota
Effects of bedtime intake of taxifolin-containing tablets on oral microbiota
Effects of bedtime intake of taxifolin-containing tablets on oral microbiota
Effects of bedtime intake of taxifolin-containing tablets on oral microbiota
| Japan |
Healthy Adults
| Adult |
Others
NO
To verify the effect of bedtime intake of taxifolin-containing tablets on salivary microbiota overnight until the next morning.
Efficacy
Nocturnal Changes in the Salivary Microbiome (16S rRNA Gene Analysis, V3-V4 Region)
Alpha diversity (e.g., Shannon index),
Beta diversity (e.g., UniFrac distance),
Proportion of periodontal disease-related bacteria (e.g., Porphyromonas, Tannerella, Treponema, Fusobacterium),
Proportion of dental caries-related bacteria (e.g., Streptococcus mutans group, Lactobacillus),
Subjective oral symptom questionnaire (stickiness in the morning, awareness of bad breath, dry mouth)
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
| Food |
Intake 1 tablet (once a day) of the test food before bedtime (single intake).
Intake 1 tablet (once a day) of the placebo food before bedtime (single intake).
| 40 | years-old | <= |
| 60 | years-old | >= |
Male and Female
1)Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document
2)Persons who are healthy males and females aged 40 years old or more and 60 years old or less
3)Persons who have 20 or more of their own teeth
1)Persons who have chronic illness, receiving medication, have a serious disease history
2)Persons who are allergic to the test food
3)Persons who usually take a large amount of test food
4)Persons who usually take medicine, functional foods for health uses (specified health foods, functional foods, and functional nutrition foods) that may have effect to salivary microbiota
5)Persons who regularly use mouthwash and cannot stop using it
6)Persons who are undergoing dental treatment, have been diagnosed with severe periodontal disease, or use dentures (removable dentures)
7)Persons who are smokers
8)Persons who have used antibacterial or antifungal drugs within 1 month prior to the start of the study
9)Persons who have participated in other studies within the first month before the start of the study, or those who intend to participate in another study after consenting to this study
10)Persons who were judged as inappropriate for study participants by the principal investigator
11)Persons who are pregnant, planning or hoping to be pregnant during the study period, breastfeeding
24
| 1st name | Takumi |
| Middle name | |
| Last name | Tochio |
Biosis Lab Co., Ltd.
President and CEO
470-1192
11-506, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, JAPAN
090-6904-6772
takumitochiobiz@gmail.com
| 1st name | Takumi |
| Middle name | |
| Last name | Tochio |
Biosis Lab Co., Ltd.
President and CEO
470-1192
11-506, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, JAPAN
090-6904-6772
takumitochiobiz@gmail.com
Biosis Lab Co., Ltd.
SANOH CORPORATION Co., Ltd.
Profit organization
The Ethics Committee of Healthcare Systems Co., Ltd.
1-14-18, Shirakane, Showa-ku, Nagoya, Aichi, JAPAN
03-6809-2722
soumu@hc-sys.jp
NO
| 2026 | Year | 11 | Month | 20 | Day |
Unpublished
Preinitiation
| 2026 | Year | 11 | Month | 19 | Day |
| 2026 | Year | 11 | Month | 19 | Day |
| 2026 | Year | 11 | Month | 21 | Day |
| 2027 | Year | 12 | Month | 31 | Day |
| 2026 | Year | 11 | Month | 20 | Day |
| 2026 | Year | 11 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072902